Pharma QC Editorial Feature

Elevate your pharmaceutical quality control practices with the latest news, technology, and resources available

Nanda Balasubramanian, Bristol Myers Squibb
Tackle challenges in bioanalysis for cutting-edge therapies

Nanda Balasubramanian discusses the pivotal role of bioanalysis in advancing pharmaceutical science. He shares key innovations in bioanalytical techniques to reduce the burden on patients and improve turnaround times of assays. Balasubramanian also addresses the unique challenges of bioanalysis for therapeutic modalities like mRNA therapeutics, CAR-T, and small molecules.

Watch interview on The Scientists' Channel